Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength (Descending) SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
42799-0812-01 42799-0812 Prednisolone Sodium Phosphate Prednisolone Sodium Phosphate 10.0 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Nov. 11, 2011 In Use
23594-0510-08 23594-0510 Prednisolone Sodium Phosphate Millipred 10.0 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral March 1, 2014 May 31, 2018 In Use
13632-0123-01 13632-0123 Tamoxifen Citrate Soltamox 10.0 mg/5mL Hormonal Therapy Selective Estrogen Receptor Modulator (SERM) Oral Oct. 1, 2012 Aug. 1, 2018 In Use
67457-0393-00 67457-0393 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 10.0 mg/5mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 14, 2012 March 31, 2016 No Longer Used
67457-0393-54 67457-0393 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 10.0 mg/5mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 14, 2012 April 30, 2013 No Longer Used
76075-0103-01 76075-0103 carfilzomib KYPROLIS 10.0 mg/5mL Chemotherapy Proteasome Inhibitor 20S Intravenous May 23, 2018 In Use
00121-0773-08 00121-0773 Prednisolone Sodium Phosphate Prednisolone Sodium Phosphate 10.0 mg/5mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Jan. 31, 2017 In Use
52584-0450-39 52584-0450 Metoclopramide Hydrochloride Metoclopramide 10.0 mg/2mL Ancillary Therapy Antiemetic Dopamine-2 Receptor Antagonist Intramuscular, Intramuscular, intravenous, Intravenous Aug. 1, 2010 Jan. 17, 2017 No Longer Used
76045-0101-20 76045-0101 Metoclopramide Hydrochloride Metoclopramide 10.0 mg/2mL Ancillary Therapy Antiemetic Dopamine-2 Receptor Antagonist Intramuscular, Intravenous May 3, 2013 In Use
79952-0110-01 79952-0110 loncastuximab tesirine ZYNLONTA 10.0 mg/2mL Immunotherapy Drug Antibody Conjugate CD19 Intravenous April 30, 2021 In Use

Found 10,000 results in 11 milliseconds — Export these results